Tuesday, July 1, 2025

Creating liberating content

Access Denied You don’t have permission to access ” on

Bay Area Rapid Transit (BART) passengers walk off a train

MUMBAI: Shadowfax has filed draft IPO papers with markets regulator

Related News

Access Denied You don’t have permission to access ” on this server. Reference #18.adf5d217.1751389020.d844a7 Source link

Hero Motors IPO: Hero Motors has refiled its draft red herring prospectus (DRHP) with the Securities and Exchange Board of India (Sebi) for an initial public offering (IPO) with an

Bay Area Rapid Transit (BART) passengers walk off a train at the Richmond station on March 15, 2023 in Richmond, California. Justin Sullivan | Getty Images Commuters in and around

MUMBAI: Shadowfax has filed draft IPO papers with markets regulator Sebi through the confidential filing route. The company is seeking to raise up to Rs 2,000-2,500 crore comprising a mix

HDB Financial Services, the non-banking finance arm of HDFC Bank, will make its stock market debut on Wednesday with grey market activity indicating a strong listing. According to ET, the

An image of a Quantix drone made by AeroVironment. David Mcnew | Getty Images News | Getty Images AeroVironment shares fell 7% Tuesday after the defense contractor said it plans

Trending News

Hero Motors IPO: Hero Motors has refiled its draft red herring prospectus (DRHP) with the Securities and Exchange Board of India (Sebi) for an initial public offering (IPO) with an

MUMBAI: Shadowfax has filed draft IPO papers with markets regulator Sebi through the confidential filing route. The company is seeking to raise up to Rs 2,000-2,500 crore comprising a mix

HDB Financial Services, the non-banking finance arm of HDFC Bank, will make its stock market debut on Wednesday with grey market activity indicating a strong listing. According to ET, the

New Delhi, The Competition Commission of India (CCI) on Tuesday ordered an investigation against Asian Paints for allegedly abusing its dominant position in the market for manufacturing and sale of

Access Denied You don’t have permission to access ” on this server. Reference #18.27fdd417.1751375768.90018f2 Source link

NEW DELHI: India’s gross Goods and Services Tax (GST) collection for June stood at Rs 1.85 lakh crore, recording a 6.2% increase over the same month last year, according to

Indian pharma stocks tumble as Trump signals tariffs on drug imports

Word Count: 621 | Estimated Reading Time: 4 minutes


Indian pharma stocks tumble as Trump signals tariffs on drug imports
This is a representational AI image (Pic credit: Lexica)

Indian pharmaceutical stocks slumped on Wednesday after US President Donald Trump renewed his threat to impose sweeping tariffs on all pharmaceutical imports, an announcement that sent shockwaves through drug industry in India, which heavily relies on exports to the US.
The Nifty Pharma index dropped 1.7 per cent, dragging the broader Nifty 50 benchmark down by 0.52 per cent as of 9.20 am IST. All 20 constituents of the pharma index were trading in the red.
Gland Pharma, Lupin, and Zydus Lifesciences were among the worst hit, plunging between 3 per cent and 5 per cent. Heavyweights Sun Pharma and Cipla also declined, slipping 1.69 per cent and 1.87 per cent, respectively.
US a key market for Indian generics
India exports a significant volume of generic drugs—low-cost alternatives to branded pharmaceuticals—to the United States, which accounts for roughly one-third of the country’s overall pharma exports. Currently, these products face minimal to no tariffs in the US, while India levies around 10 per cent on pharmaceutical imports from America, according to industry analysts.
Speaking at the National Building Museum in Washington late Tuesday, Trump indicated that pharmaceutical imports would soon face hefty new tariffs.
“Tariffs on pharma will be there because we don’t make our own pharma drugs; they are made in another country. The same packet in the US is priced at USD 10 or more. We are going to tariff pharma in such a way that companies will come rushing to us very soon. The advantage we have is, we are very big market. Very shortly, will announce a major tariff on pharma, and when these companies hear that, they will leave China and other countries because most of their products are sold here. And they will be opening their plants here,” Trump said.





Source link

Most Popular Articles

Sign In

Welcome ! Log into Your Account